Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Moderna

A whale with a lot of money to spend has taken a noticeably bearish stance on Moderna. Looking at options history for Moderna (NASDAQ:MRNA) we detected 13 strange trades.

Benzinga

Walmart And 3 Other Stocks Insiders Are Selling

US stock futures traded slightly higher this morning on Monday after recording sharp gains in the previous session. Investors, meanwhile, focused on some notable insider trades.

Benzinga

Should you get a COVID-19 booster shot now or wait until fall? Two immunologists help weigh the options

While COVID-19 vaccines continue to be highly effective at preventing hospitalization and death, it has become clear that the protection offered by the current vaccines wanes over time. This necessitates the use of booster shots that are safe and effective in enhancing the immune response against the virus and extending…

The Conversation

From analysis to the latest developments in health,
read the most diverse news in one place.

UK among worst offenders in G7 vaccine supply failures ‘which led to 600,000 preventable deaths’

With days left until Britain reaches the deadline to fulfil its 100 million dose pledge, only 39 per cent have actually been delivered

The Independent UK

Pfizer says its tweaked COVID-19 shots boost protection against the omicron variant

Pfizer said that tweaking its vaccine to better target the omicron variant is safe and works — just days before regulators debate whether to offer Americans updated booster shots this fall.

WEKU

Pfizer says tweaked COVID-19 shots boost omicron protection

Pfizer says tweaking its COVID-19 vaccine to better target the omicron variant is safe and boosts protection

The Independent UK

Moderna COVID-19 shots now an option for older kids in US

There is now a second COVID-19 option for kids ages 6 to 17 in the U.S. The Centers for Disease Control and Prevention on Friday announced it is recommending Moderna shots as an option for school-age kids and teens

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Moderna Has Multi-Billion-Dollar Opportunity Outside Of COVID-19 Vaccines, Analyst Says

Moderna, Inc. (NASDAQ: MRNA) rose to prominence with its messenger RNA-based COVID-19 vaccine.

Benzinga

Dow Jones Gains; Tesla Falls After Elon Musk Reveals These Fears; This Stock Up As Warren Buffett Raises Stake

The Dow Jones moved higher as yields fell. Tesla stock skidded after CEO Elon Musk voiced a warning. A Warren Buffett stock rose.

Investors Business Daily

Experts endorse Moderna COVID-19 shots for kids ages 6 to 17

An expert panel backed a second COVID-19 vaccine option for kids ages 6 to 17

The Independent UK

Research behind COVID vaccines reaps close to $1 billion in royalties for Penn

PHILADELPHIA — The University of Pennsylvania has reaped extraordinary financial gain from COVID-19 vaccines — approaching $1 billion since the beginning of last year — thanks to patents on a process Penn researchers developed more than 15 years ago.

The Philadelphia Inquirer

Moderna confirms two-in-one Covid and flu jab in the works as testing under way

Scientists have developed an alternative to the current separate inoculations with the trial already under

Daily Record

This Is What Whales Are Betting On Moderna

Someone with a lot of money to spend has taken a bullish stance on Moderna (NASDAQ:MRNA). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Young adults and children should get Covid booster jabs this autumn, vaccine chiefs warn

The announcement comes after the UK is seeing a spike in Covid-19 cases and follows a trial of Moderna's new vaccine designed to tackle the more contagious sub-variants of Omicron

Daily Mirror

Get all your
news in one place.

100’s of premium titles.
One news app.

Wales Online

Two-in-one covid and flu jab in pipeline with testing under way

Vaccination developer Moderna is calling for action on the current jab programme warning people could find themselves 'under-protected and under-vaccinated'

Benzinga

So What's Going On With Moderna Shares Rising Today?

Moderna Inc (NASDAQ: MRNA) shares are trading higher after the company released data on its bivalent COVID booster candidate. Data showed potent neutralizing antibody responses against the omicron subvariants BA.4 and BA.5.

The Guardian - UK

Moderna to build UK’s first mRNA vaccine research and manufacturing centre

US biotech firm agrees £1bn deal with government for centre to combat Covid and other illnesses

The Independent UK

Call for autumn booster programme to be extended

It comes as Moderna announced that its variant vaccine can create a strong antibody response to the BA.4 and the BA.5 variants.

Get all your
news in one place.

100’s of premium titles.
One news app.

Los Angeles Times

2 million California kids are now eligible for COVID vaccine. How many will get it?

LOS ANGELES — Jonah Stein exited the vaccination clinic in his father’s arms Tuesday afternoon, proud to show off his Band-Aid.

Benzinga

Moderna's Bivalent COVID-19 Booster Shows Antibody Response Against Omicron Subvariants

Moderna Inc (NASDAQ:MRNA) has released new clinical data on its bivalent (omicron) COVID booster candidate, mRNA-1273.214. One month after administration in previously vaccinated and boosted participants, a 50 µg booster dose of mRNA-1273.214 elicited potent neutralizing antibody responses against the omicron subvariants BA.4 and BA.5. The company is working on completing regulatory submissions…

Benzinga

Benzinga Before The Bell: Executive Shakeup At Amazon, Boeing Supply Chain Warning, Apple's Tim Cook Says 'Stay Tuned' On AR/MR And Other Top Financial Stories Wednesday, June 22

CNBC Moderna To establish New Vaccine Facility In Britain

Benzinga

Moderna To establish New Vaccine Facility In Britain

Moderna Inc (NASDAQ:MRNA) announced an agreement with the United Kingdom government to establish an mRNA Innovation and Technology Center in the U.K. Additionally, Moderna plans to expand its presence in the U.K. through investments in R&D activities. Moderna is collaborating with the National Institute for Health Research on a Phase 3 study…

Evening Standard

Government’s Moderna partnership to bring over £1 billion investment

A partnership to open a new research and manufacturing centre in the UK will mean over £1 billion in mRNA research investment.

ABC News

COVID-19 vaccine from Moderna 'provides good clinical protection' against Omicron subvariants

The biotech company's experimental Omicron booster generates high levels of antibodies that neutralise subvariants BA.4 and BA.5, according to preliminary clinical trial data.

WEKU

COVID vaccines are finally here for young kids. But the logistics aren't easy

NPR talks to Claire Hannan, who has helped navigate vaccine rollouts in all 50 states, about some of the challenges involved in quickly getting shots out to millions of young kids.

1 … 22 23 24 25

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations